Literature DB >> 21664597

Risk factors for primary open-angle glaucoma and pseudoexfoliative glaucoma in the Thessaloniki eye study.

Fotis Topouzis1, M Roy Wilson, Alon Harris, Panayiota Founti, Fei Yu, Eleftherios Anastasopoulos, Theofanis Pappas, Archimidis Koskosas, Angeliki Salonikiou, Anne L Coleman.   

Abstract

PURPOSE: To investigate risk factors for primary open-angle glaucoma (POAG) and pseudoexfoliative glaucoma (PEXG) in the Thessaloniki Eye Study.
DESIGN: Cross-sectional, population-based study.
METHODS: Randomly selected subjects 60 years of age and older (n=2554) participated in the Thessaloniki Eye Study. Glaucomatous damage and presence of pseudoexfoliation (PEX) were defined according to specific criteria. Open-angle glaucoma (OAG) subjects were compared with nonglaucoma subjects (controls), POAG subjects were compared with controls without PEX, and PEXG subjects were compared with controls with PEX for demographic, lifestyle, ophthalmic, and systemic factors. Factors with P < .2 in the univariate analysis were retained for multivariate analyses.
RESULTS: In multivariate analysis restricted to persons who participated in clinic visits and who had at least 1 phakic eye (n=2078), intraocular pressure (odds ratio [OR], 1.21 per 1 mm Hg; P<.001), PEX (OR, 2.81; P<.001), history of coronary artery bypass or vascular surgery (OR, 1.95; P=.017), and moderate-to-high myopia (≥ -3 diopters; OR, 2.40; P=.009) were associated with higher odds for OAG. In analysis including all clinic visits (n=2261), age became significantly associated (OR, 1.05; P=.004). In multivariate analysis for POAG (n=1840), associations were found for age (OR, 1.04 per year; P=.048), IOP (OR, 1.19 per 1 mm Hg; P<.001), history of coronary artery bypass or vascular surgery (OR, 2.09; P=.01), and history of diabetes treated with insulin (OR, 3.05; P=.045). In multivariate analysis for PEXG (n=238), the latter was associated with increased IOP (OR, 1.25 per 1 mm Hg; P<.001).
CONCLUSIONS: IOP was the only factor associated with both POAG and PEXG, whereas moderate-to-high myopia showed borderline significance in both. Vascular systemic diseases and their treatment were associated only with POAG. The implications of these differences for the pathogenesis between the 2 common types of OAG should be explored further.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21664597     DOI: 10.1016/j.ajo.2011.01.032

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  30 in total

1.  Cigarette smoking and glaucoma in the United States population.

Authors:  S M Law; X Lu; F Yu; V Tseng; S K Law; A L Coleman
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

2.  Meta-analysis of the efficacy and safety of combined surgery in the management of eyes with coexisting cataract and open angle glaucoma.

Authors:  Nan Jiang; Gui-Qiu Zhao; Jing Lin; Li-Ting Hu; Cheng-Ye Che; Qian Wang; Qiang Xu; Cui Li; Jie Zhang
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

3.  Genome-wide association study identifies seven novel susceptibility loci for primary open-angle glaucoma.

Authors:  Yukihiro Shiga; Masato Akiyama; Koji M Nishiguchi; Kota Sato; Nobuhiro Shimozawa; Atsushi Takahashi; Yukihide Momozawa; Makoto Hirata; Koichi Matsuda; Taiki Yamaji; Motoki Iwasaki; Shoichiro Tsugane; Isao Oze; Haruo Mikami; Mariko Naito; Kenji Wakai; Munemitsu Yoshikawa; Masahiro Miyake; Kenji Yamashiro; Kenji Kashiwagi; Takeshi Iwata; Fumihiko Mabuchi; Mitsuko Takamoto; Mineo Ozaki; Kazuhide Kawase; Makoto Aihara; Makoto Araie; Tetsuya Yamamoto; Yoshiaki Kiuchi; Makoto Nakamura; Yasuhiro Ikeda; Koh-Hei Sonoda; Tatsuro Ishibashi; Koji Nitta; Aiko Iwase; Shiroaki Shirato; Yoshitaka Oka; Mamoru Satoh; Makoto Sasaki; Nobuo Fuse; Yoichi Suzuki; Ching-Yu Cheng; Chiea Chuen Khor; Mani Baskaran; Shamira Perera; Tin Aung; Eranga N Vithana; Jessica N Cooke Bailey; Jae H Kang; Louis R Pasquale; Jonathan L Haines; Janey L Wiggs; Kathryn P Burdon; Puya Gharahkhani; Alex W Hewitt; David A Mackey; Stuart MacGregor; Jamie E Craig; R Rand Allingham; Micheal Hauser; Adeyinka Ashaye; Donald L Budenz; Stephan Akafo; Susan E I Williams; Yoichiro Kamatani; Toru Nakazawa; Michiaki Kubo
Journal:  Hum Mol Genet       Date:  2018-04-15       Impact factor: 6.150

Review 4.  [Glaucoma treatment in high myopia].

Authors:  B Voykov; J M Rohrbach
Journal:  Ophthalmologe       Date:  2019-05       Impact factor: 1.059

5.  Retinal vascular caliber between eyes with asymmetric glaucoma.

Authors:  John Mark S De Leon; Carol Y Cheung; Tien-Yin Wong; Xiang Li; Haslina Hamzah; Tin Aung; Daniel Hsien-Wen Su
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-21       Impact factor: 3.117

Review 6.  Association Between Diabetes, Diabetic Retinopathy, and Glaucoma.

Authors:  Yangjiani Li; William Mitchell; Tobias Elze; Nazlee Zebardast
Journal:  Curr Diab Rep       Date:  2021-09-08       Impact factor: 5.430

7.  Association of LOXL1 polymorphisms with pseudoexfoliation, glaucoma, intraocular pressure, and systemic diseases in a Greek population. The Thessaloniki eye study.

Authors:  Eleftherios Anastasopoulos; Anne L Coleman; M Roy Wilson; Janet S Sinsheimer; Fei Yu; Sokratis Katafigiotis; Panayiota Founti; Angeliki Salonikiou; Theofanis Pappas; Archimidis Koskosas; Theodora Katopodi; Alexandros Lambropoulos; Fotis Topouzis
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-10       Impact factor: 4.799

8.  Pharmacological regulation of outflow resistance distal to Schlemm's canal.

Authors:  Fiona McDonnell; W Michael Dismuke; Darryl R Overby; W Daniel Stamer
Journal:  Am J Physiol Cell Physiol       Date:  2018-04-06       Impact factor: 4.249

9.  Helicobacter pylori infection, dementia and primary open-angle glaucoma: are they connected?

Authors:  Fani Tsolaki; Jannis Kountouras; Fotios Topouzis; Magda Tsolaki
Journal:  BMC Ophthalmol       Date:  2015-03-11       Impact factor: 2.209

Review 10.  Management of exfoliative glaucoma: challenges and solutions.

Authors:  Gábor Holló; Andreas Katsanos; Anastasios Gp Konstas
Journal:  Clin Ophthalmol       Date:  2015-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.